Literature DB >> 9647934

Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities.

G M Alexander1, R S Swerdloff, C Wang, T Davidson, V McDonald, B Steiner, M Hines.   

Abstract

Sex-typed cognitive abilities were assessed in 33 hypogonadal men receiving testosterone replacement therapy, 10 eugonadal men receiving testosterone in a male contraceptive clinical trial, and 19 eugonadal men not administered testosterone. Prior to and following hormone administration, men completed four tests measuring visuospatial ability, three tests measuring verbal fluency, two tests measuring perceptual speed, and a measure of verbal memory. Group differences in testosterone levels were unrelated to performance on most cognitive measures, including visuospatial ability. Relative to other men, hypogonadal men were impaired in their verbal fluency and showed improved verbal fluency following treatment with testosterone. These data suggest that testosterone may enhance verbal fluency in hypogonadal men and support the general hypothesis that current levels of testosterone may influence some aspects of cognitive function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647934     DOI: 10.1006/hbeh.1998.1439

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  28 in total

Review 1.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

2.  Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men.

Authors:  M M Cherrier; A M Matsumoto; J K Amory; M Johnson; S Craft; E R Peskind; M A Raskind
Journal:  Psychoneuroendocrinology       Date:  2006-12-04       Impact factor: 4.905

Review 3.  Effects of Testosterone Therapy on Cognitive Function in Aging: A Systematic Review.

Authors:  Jeremy T Hua; Kerry L Hildreth; Victoria S Pelak
Journal:  Cogn Behav Neurol       Date:  2016-09       Impact factor: 1.600

4.  Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.

Authors:  Daniel F Kelly; Charlene Chaloner; Diana Evans; Amy Mathews; Pejman Cohan; Christina Wang; Ronald Swerdloff; Myung-Shin Sim; Jihey Lee; Mathew J Wright; Claudia Kernan; Garni Barkhoudarian; Kevin C J Yuen; Kevin Guskiewicz
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

Review 5.  Cognitive effects of hormone therapy in men with prostate cancer: a review.

Authors:  Christian J Nelson; Jennifer S Lee; Maria C Gamboa; Andrew J Roth
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

6.  Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.

Authors:  B Meyers; A D'Agostino; J Walker; M F Kritzer
Journal:  Neuroscience       Date:  2009-11-10       Impact factor: 3.590

7.  Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women.

Authors:  Wael K Al-Delaimy; Denise von Muhlen; Elizabeth Barrett-Connor
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

8.  3alpha-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats.

Authors:  Cheryl A Frye; Kassandra L Edinger; Edwin D Lephart; Alicia A Walf
Journal:  Front Aging Neurosci       Date:  2010-04-08       Impact factor: 5.750

9.  Blocks and bodies: sex differences in a novel version of the Mental Rotations Test.

Authors:  Gerianne M Alexander; Milagros Evardone
Journal:  Horm Behav       Date:  2007-09-29       Impact factor: 3.587

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.